课题基金 / 基金详情

Functional analysis of intracellular factors involved in the growth, differentiation, and transformation of lymphocytes

Functional analysis of intracellular factors involved in the growth, differentiation, and transformation of lymphocytes
参与淋巴细胞生长、分化和转化的细胞内因子的功能分析
批准号:
04404034
负责人:
TANIGUCHI Tadatsugu
金额:
$19.84万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for General Scientific Research (A)
财政年份:
1992
资助国家:
日本
项目状态:
已结题
起止时间:
1992 至 1994

项目摘要

项目成果

TANIGUCHI Tadatsugu的其他基金

相似基金

相关文献

中文摘要
翻译
IRF-1是在干扰素系统中起作用的转录因子。我们观察到,在IRF-1缺陷小鼠的胚胎成纤维细胞中,激活的Ha-ras基因的表达导致了它们的致癌转化,这表明IRF-1可以作为抗癌基因发挥作用。我们还观察到ha -ras诱导的细胞凋亡不会发生在缺乏IRF-1的胚胎成纤维细胞中。这些结果强烈提示IRF-1可以决定癌基因诱导的细胞转化和死亡。IRF-1映射到染色体5q区域,该区域在患有白血病或白血病前骨髓增生异常综合征(MDS)的患者中经常缺失。我们之前已经证明,IRF-1在这些“5q综合征”患者中是一个关键缺失的基因。最近,我们发现了IRF-1 mRNA的一种选择性剪接形式,它编码一种缺乏dna结合和抗致癌活性的蛋白质。我们在大约20%的白血病或MDS患者中发现了这种异常剪接产物,而不是正常的IRF-1 mRNA。因此,异常剪接可能代表了IRF-1失活的新机制,从而促进白血病的发展。我们还发现,Syk是一种非受体型蛋白激酶(PTK),与白细胞介素-2受体β链(IL-2Rbeta)的细胞内“富含丝氨酸”区域相关,并在IL-2刺激时被激活。这个“富含丝氨酸”的区域对于诱导c-myc基因和IL-2刺激后的细胞增殖至关重要。此外,我们发现最近发现的两个Jak PTK家族成员,Jak-1和Jak-3,分别与IL-2Rbeta和-g链的区域特异性相关,这些区域对IL-2信号的传递至关重要,并在IL-2刺激时迅速激活。Jak-3在NIH 3T3成纤维细胞中异位表达,表达功能性内源性IL-2R和Jak-1,赋予这些细胞对IL-2作出反应的能力,从而从细胞周期的G1期进展到S期。少
英文摘要
IRF-1 is a transcription factor that functions in the interferon system. We observed that expression of an activated Ha-ras gene in embryo fibroblasts from IRF-1-deficient mice resulted in their oncogenic transformation, indicating that IRF-1 can function as an anti-oncogene. We also observed that Ha-ras-induced apoptosis did not occur in embryo fibroblasts lacking IRF-1. These results strongly suggest that IRF-1 can determine oncogene-induced cell transformation and death. IRF-1 maps to the chromosomal 5q regon, a region frequently deleted in patients afflicted with leukemia or preleukemic myelodysplastic syndrome (MDS). We have shown previously that IRF-1 is a critically-deleted gene in these "5q syndrome" patients. Recently we discovered the existence of an alternatively-spliced form of the IRF-1 mRNA that encodes a protein lacking DNA-binding and anti-oncogenic activities. We found this abnormally-spliced product, but not the normal IRF-1 mRNA,in approximately 20% of patients affli … More cted with leukemia or MDS.Abnormal splicing may thus represent a new mechanism by which IRF-1 is inactivated, thereby promoting the development of leukemia.We have also found that Syk, a non-receptor-type protein kinase (PTK), associates with the intracellular "serine-rich" region of the interleukin-2 receptor beta chain (IL-2Rbeta) and is activated upon IL-2 stimulation. This "serine-rich" region is essential for induction of the c-myc gene and cell proliferation following IL-2 stimulation. Furthermore, we have found that two recently-identified members of the Jak PTK family, Jak-1 and Jak-3, specifically associate with regions of the IL-2Rbeta and -g chains, respoctively, which are critical for transmission of the IL-2 signal, and are rapidly activated upon IL-2 stimulation. Ectopic expression of Jak-3 in NIH 3T3 fibroblasts, which express functional endogenous IL-2R and Jak-1, conferred upon these cells the ability to respond to IL-2 and thereby progress from the G1 to S phase of the cell cycle. Less
期刊论文(27)
专著(0)
科研奖励(0)
会议论文
Tadatsugu Taniguchi: "The IL-2/IL-2 receptor system:A current overview" Cell. 73. 5-8 (1993)
Tadatsugu Taniguchi:“IL-2/IL-2 受体系统:当前概述”细胞。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Nobuyuki Tanaka: "Cellular commitment to oncogene-induced transformatin or apoptosis is dependent on the transcription factor IRF-1." Cell. 77. 829-839 (1994)
Nobuyuki Tanaka:“细胞对癌基因诱导的转化蛋白或细胞凋亡的承诺取决于转录因子 IRF-1。”
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Toru Kimura: "Involvemento of the IRF-1 transcription factor in antiviral responses to interferoms" Science. 264. 1921-1924 (1994)
Toru Kimura:“IRF-1 转录因子参与干扰素的抗病毒反应”《科学》。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
共 27 条
    Innate immune system activation and regulation via DNA receptors.
    • 批准号:
      19209016
    • 项目类别:
      Grant-in-Aid for Scientific Research (A)
    • 资助金额:
      $29.2万
    • 财政年份:
      2007
    • 负责人:
      TANIGUCHI Tadatsugu
    • 依托单位:
    Informatory expression system connecting cancer and immunity.
    • 批准号:
      17012005
    • 项目类别:
      Grant-in-Aid for Scientific Research on Priority Areas
    • 资助金额:
      $267.01万
    • 财政年份:
      2005
    • 负责人:
      TANIGUCHI Tadatsugu
    • 依托单位:
    New Frontiers of Cancer Sciences
    • 批准号:
      17012004
    • 项目类别:
      Grant-in-Aid for Scientific Research on Priority Areas
    • 资助金额:
      $5.38万
    • 财政年份:
      2005
    • 负责人:
      TANIGUCHI Tadatsugu
    • 依托单位:
    Gene expression network for tumor suppression
    • 批准号:
      12219204
    • 项目类别:
      Grant-in-Aid for Scientific Research on Priority Areas
    • 资助金额:
      $261.06万
    • 财政年份:
      2000
    • 负责人:
      TANIGUCHI Tadatsugu
    • 依托单位:
    海外基金